<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26927" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Percutaneous Coronary Intervention</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Mansoor</given-names>
          </name>
          <aff>UIC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mehta</surname>
            <given-names>Parth</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reddivari</surname>
            <given-names>Anil Kumar Reddy</given-names>
          </name>
          <aff>University of Illinois</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mungee</surname>
            <given-names>Sudhir</given-names>
          </name>
          <aff>University of Illinois Peoria</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mansoor Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Parth Mehta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anil Kumar Reddy Reddivari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sudhir Mungee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26927.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Coronary artery disease (CAD) is one of the leading causes of death. Percutaneous coronary intervention (PCI) is a non-surgical, invasive procedure with a goal to relieve the narrowing or occlusion of the coronary artery and improve blood supply to the ischemic tissue. This is usually achieved by different methods, the most common being ballooning the narrow segment or deploying a stent to keep the artery open. This activity describes the indications for PCI and highlights the role of the interprofessional team in managing patients with CAD.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the indications for percutaneous coronary intervention.</p></list-item><list-item><p>Outline the technique of percutaneous coronary intervention.</p></list-item><list-item><p>Summarize the complications of percutaneous coronary intervention.</p></list-item><list-item><p>Outline the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients undergoing PCI.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26927&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26927">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26927.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Coronary&#x000a0;artery disease (CAD) is one of the leading causes of death. Percutaneous coronary intervention (PCI) is a non-surgical, invasive procedure with the goal&#x000a0;of relieving the narrowing or occlusion of&#x000a0;the coronary artery and improve blood supply to the ischemic tissue. This is usually achieved by different methods, the most common being ballooning the narrow segment or deploying a stent to keep the artery open.</p>
      </sec>
      <sec id="article-26927.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Access to the bloodstream is achieved through either the femoral or radial artery. Real-time X-ray fluoroscopy is used to visualize the location of the catheter and tissues. The catheter is advanced to ascending aorta. Coronary arteries are engaged using different catheters for the right and left coronary artery.&#x000a0; IV contrast is introduced in the coronary artery to delineate the anatomy. Pictures of coronary arteries are taken from different angles to help access the three-dimensional&#x000a0;nature of the narrowing.</p>
      </sec>
      <sec id="article-26927.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The following are the clinical indications that could require a percutaneous coronary intervention.</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute ST-elevation myocardial infarction (STEMI)
<list list-type="bullet"><list-item><p>Primary PCI is the recommended method of reperfusion when it can be performed in a timely fashion by experienced operators.<xref ref-type="bibr" rid="article-26927.r1">[1]</xref></p></list-item><list-item><p>STEMI and ischemic symptoms of less than 12 hours' duration.<xref ref-type="bibr" rid="article-26927.r2">[2]</xref></p></list-item><list-item><p>STEMI and ischemic symptoms of less than 12 hours' duration and contraindications to fibrinolytic therapy</p></list-item><list-item><p>PCI improves survival in patients with significant (&#x0003e;50%) stenosis</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Non&#x02013;ST-elevation acute coronary syndrome (NSTE-ACS)&#x000a0;
<list list-type="bullet"><list-item><p>Early invasive therapy (within 2 hours of symptoms) recommended with refractory angina, recurrent angina, symptoms of heart failure, new or worsening mitral regurgitation, hemodynamic instability, or sustained ventricular tachycardia/fibrillation.</p></list-item><list-item><p>A worsening of troponin levels should trigger an early therapy (within 24 hours)</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Unstable angina</p>
          </list-item>
          <list-item>
            <p>Stable angina</p>
          </list-item>
          <list-item>
            <p>Anginal equivalent (e.g., dyspnea, arrhythmia, or dizziness or syncope)</p>
          </list-item>
          <list-item>
            <p>High-risk stress test findings</p>
          </list-item>
          <list-item>
            <p>PCI is indicated for critical coronary artery stenosis, which does not qualify for coronary artery bypass surgery (CABG).<xref ref-type="bibr" rid="article-26927.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>
<bold>Absolute Contraindications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Noncompliance with the procedure and inability to take dual antiplatelet therapy.</p>
          </list-item>
          <list-item>
            <p>High bleeding risk (thrombocytopenia, peptic ulcer, severe coagulopathy)</p>
          </list-item>
          <list-item>
            <p>Multiple percutaneous coronary intervention restenosis</p>
          </list-item>
        </list>
        <p>
<bold>Relative Contraindications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Intolerance for oral antiplatelets long-term</p>
          </list-item>
          <list-item>
            <p>Absence of cardiac surgery backup</p>
          </list-item>
          <list-item>
            <p>Hypercoagulable state</p>
          </list-item>
          <list-item>
            <p>High-grade chronic kidney disease</p>
          </list-item>
          <list-item>
            <p>Chronic total occlusion of SVG</p>
          </list-item>
          <list-item>
            <p>An artery with a diameter of &#x0003c;1.5 mm</p>
          </list-item>
          <list-item>
            <p>Stenosis of &#x0003c;50%</p>
          </list-item>
          <list-item>
            <p>Critical left main stenosis with no collateral flow or patent bypass graft.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Percutaneous coronary intervention is performed during an angiogram in the angiography suite. Other than standard equipment, the following supplies may be used on a case-to-case basis.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Introducer needle</p>
          </list-item>
          <list-item>
            <p>Sheath introducer</p>
          </list-item>
          <list-item>
            <p>Guide catheters</p>
          </list-item>
          <list-item>
            <p>Radioopaque dye (IV contrast)</p>
          </list-item>
          <list-item>
            <p>Guidewire</p>
          </list-item>
          <list-item>
            <p>Balloon catheter</p>
          </list-item>
          <list-item>
            <p>Stents
<list list-type="bullet"><list-item><p>Bare metal stents (BMS)
<list list-type="bullet"><list-item><p>Preferred if the patient is not able to take a longer duration of dual antiplatelet therapy (DAPT). A minimum of 1 month of DAPT is required.</p></list-item></list>
</p></list-item><list-item><p>Drug-eluting stents (DES)
<list list-type="bullet"><list-item><p>Found to have reduced restenosis and revascularization rates compared with BMS.</p></list-item></list>
</p></list-item><list-item><p>Bioresorbable vascular scaffold (BVS)</p></list-item><list-item><p>Drug-eluting balloons (DEB)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Thrombus aspiration:
<list list-type="bullet"><list-item><p>Not recommended routinely&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Guidelines</p>
          </list-item>
          <list-item>
            <p>Atherectomy devices
<list list-type="bullet"><list-item><p>Rotational</p></list-item><list-item><p>Laser</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Cutting balloons</p>
          </list-item>
          <list-item>
            <p>Radiation beads</p>
          </list-item>
          <list-item>
            <p>Lithoplasty/lithotripsy systems</p>
          </list-item>
        </list>
        <p>
<bold>Door to Balloon Time</bold>
</p>
        <p>The door-to-balloon time (D2B time) is used as a measure to improve the timing of PCI in patients with STEMI.&#x000a0; It defines a time taken between a patient's arrival to balloon inflation during the angiogram.&#x000a0; Studies have shown improved in-hospital mortality, which showed a shorter&#x000a0;door to balloon times. ST-elevation myocardial infarction (STEMI) patients in the NRMI-3 and 4 registries (1999 to 2002) who were treated with percutaneous coronary intervention (PCI) within six hours of presentation, longer D2B times were significantly associated with increased in-hospital mortality (3.0, 4.2, 5.7, and 7.4 percent for D2B time of less than or equal to 90 minutes, 91 to 120 minutes, 121 to 150 minutes, and greater than 150 minutes, respectively).<xref ref-type="bibr" rid="article-26927.r4">[4]</xref></p>
        <p>
<bold>Access Type: Femoral vs. Radial Access</bold>
</p>
        <p>Coronary arteries can be accessed for angiogram through a radial or femoral approach. In general, the radial artery approach is preferred to reduce the risk of access site bleeding because the radial artery can be easily compressed against the radial bone compared to the femoral artery. However, access to the radial artery requires more experience and expertise because of its small size.</p>
        <p>Before access through the radial artery, palmar arch circulation should be assessed to avoid ischemia of the hand from complications during the procedure.</p>
        <p>A meta-analysis was done in 2016, based on 24 trials for acute coronary syndrome patients: RIVAL, MATRIX, RIFLE-STEACS, and STEMI RADIAL: Showed a reduction in following endpoints in patients who had the procedure done through the radial approach.</p>
        <list list-type="bullet">
          <list-item>
            <p>Major bleeding</p>
          </list-item>
          <list-item>
            <p>All-cause mortality</p>
          </list-item>
          <list-item>
            <p>Major adverse cardiovascular events</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>
<bold>Antiplatelet Therapy and Indication in Percutaneous Coronary Intervention</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Aspirin 162 to 325 mg is given on the day of PCI.</p>
          </list-item>
          <list-item>
            <p>Unfractionated heparin may be used at the time of PCI</p>
          </list-item>
          <list-item>
            <p>Glycoprotein IIb/IIIa inhibitors: (abciximab, tirofiban, and eptifibatide) have shown a reduction in complications with PCI.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dual antiplatelet therapy (DAPT) is a combination of aspirin (usually low dose, 81mg) with a P2Y12 inhibitor (clopidogrel, prasugrel, ticagrelor).
<list list-type="order"><list-item><p>Duration of DAPT after PCI:<xref ref-type="bibr" rid="article-26927.r5">[5]</xref>
<list list-type="order"><list-item><p>PCI after Acute Coronary Syndrome (STEMI and non-STEMI): The minimum duration is 1 year irrespective of stent type.</p></list-item><list-item><p>In patients with stable ischemic heart disease, who required PCI, DAPT should be continued for at least
<list list-type="bullet"><list-item><p>1 month in patients who required BMS</p></list-item><list-item><p>6 months in those who required DES.</p></list-item></list>
</p></list-item></list>
</p></list-item><list-item><p>Interruption of DAPT:
<list list-type="order"><list-item><p>High bleeding risk:<xref ref-type="bibr" rid="article-26927.r6">[6]</xref>
<list list-type="bullet"><list-item><p>Reasonable to stop after 6 months in patients with ACS who had PCI</p></list-item><list-item><p>Reasonable to stop after 3 months in patients with SIHD who had PCI with DES</p></list-item><list-item><p>Reasonable to stop after 1 month in patients with SIHD who had PCI with BMS</p></list-item></list>
</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Angiography</bold>
</p>
        <p>After preparing the access site for approach, usually&#x000a0;the groin for the femoral artery approach, an introducer needle is inserted in the artery. A guidewire is passed, and the needle is withdrawn. Once the access is gained, a "sheath introducer" is inserted over the guidewire, which helps to keep the artery open. A sheath is then inserted through the sheath introducer.&#x000a0;The sheaths are flexible hollow tubes used to introduce different catheters.&#x000a0;Different types of sheaths are used to access different locations like right and left coronary arteries and left ventricle. With X-ray fluoroscopy, contrast material is introduced in the coronary artery to delineate its anatomy. Stenosis or occlusion of the coronary artery is then visualized, and severity is estimated through pictures at different angles. If stenosis or occlusion is located, the cardiologist then introduces a guidewire through the catheter and positions the tip of the wire distal to the stenosis in the artery. This guidewire is then used to introduce the balloon or stent catheter over it for angioplasty or stent placement, respectively. For stent placement, the catheter has the stent positioned over the balloon, and once in the right location, the balloon can be expanded, which stretches the stent open over the balloon. The catheter can then be withdrawn. Images are taken to confirm the proper location of the stent and resolution of stenosis.</p>
        <p>Percutaneous coronary intervention</p>
        <list list-type="order">
          <list-item>
            <p><bold>Balloon Angioplasty </bold>
<list list-type="bullet"><list-item><p>A form of PCI involving the inflation of a balloon inside a coronary artery to open the narrowing. It leads to the disruption of plaque. This procedure is not the primary&#x000a0;intervention anymore because, over time, the ballooned artery&#x000a0;returns to the stenotic state. It is, however, performed when stent placement is either not possible or will be harmful. It can also be performed as a bridge to CABG or future PCI.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Stent Implantation</bold>
<list list-type="bullet"><list-item><p>If a coronary stent is required, the catheter containing a stent (over the balloon) is advanced over the guidewire and appropriately positioned in the stenotic segment of the coronary artery; the balloon is then expanded. The stent, which is located over the balloon, expands and deploys in position, relieving the stenosis.</p></list-item><list-item><p>Stent placement can be done mainly by 2 methods: direct stenting or pre-dilation and stenting.&#x000a0;<bold>Pre-dilation</bold> involves dilation of the balloon in the stenosed segment, followed by stent placement. Direct<bold> stenting</bold> involves a low-profile stent delivery system, which can be introduced directly to the lesion, and the stent is deployed without pre-dilation. The efficacy of this approach was best evaluated in a randomized trial of 206 patients with an acute STEMI who underwent primary stenting with or without pre-dilation. Although the incidence of TIMI flow grade 3 and the corrected TIMI frame count was the same with both approaches, the incidence of the composite angiographic endpoint (slow and no-reflow or distal embolization) was significantly lower with direct stenting (12 versus 27 percent with pre-dilation before stenting), and ST-segment resolution was more frequent (80 versus 62 percent).<xref ref-type="bibr" rid="article-26927.r7">[7]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Atherectomy</bold>
<list list-type="bullet"><list-item><p>Coronary atherectomy is an invasive procedure to physically remove blockage (atheroma, calcium, or cellular debris) from coronary arteries. It works by cutting the lesions with a cutter, usually a burr or crown. Directional coronary atherectomy and laser atherectomy are two major types of atherectomy. Atherectomy is typically followed by balloon and stent placement.&#x000a0;</p></list-item><list-item><p>If a calcified segment prevents the delivery of a stent in a blood vessel, atherectomy is useful; however, routine use of atherectomy before stenting has not been shown to improve the outcomes and should be avoided when not required.<xref ref-type="bibr" rid="article-26927.r8">[8]</xref></p></list-item><list-item><p>Rotational atherectomy may be infrequently required for internal mammary artery graft stenosis, although common practice is angioplasty.</p></list-item><list-item><p>Atherectomy is a less favored procedure for saphenous vein graft lesions.</p></list-item><list-item><p>In patients with diabetes, Angiographic restenosis at 6 months post atherectomy was found to be higher, and this atherectomy should be avoided if not necessary.<xref ref-type="bibr" rid="article-26927.r9">[9]</xref></p></list-item><list-item><p>The complications of atherectomy include:
<list list-type="bullet"><list-item><p>arterial dissection</p></list-item><list-item><p>coronary artery perforation</p></list-item><list-item><p>coronary spasm</p></list-item><list-item><p>particle embolization</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Brachytherapy</bold>
<list list-type="bullet"><list-item><p>Involves intracoronary irradiation to prevent restenosis of stents. It showed a reduction in-stent restenosis in BMS, but after DESs&#x000a0;were introduced, in-stent restenosis has decreased, so did the use of brachytherapy.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>
<bold>IVUS</bold>
</p>
            <p>Intravascular ultrasound (IVUS) enables visualization up the coronary artery wall using a mini ager ultrasound transducer at the end of the flexible catheter; it helps in delineating the plaque morphology and distribution and helps in rationalizing the PCI.&#x000a0;The benefit of IVUS is in the utility of intra-lumen measurements, which is not possible with coronary angiography as the view taken is usually two-dimensional and does not represent the true lumen diameter accurately because of limitations of contrast enhancement, angle of view, especially in asymmetric narrowing and complex luminal shapes.</p>
            <list list-type="bullet">
              <list-item>
                <p>The routine use of this technology to identify nonobstructive lesions at increased risk was evaluated in a study of 1563 patients with suspected coronary artery disease who underwent cardiac catheterization with possible ad hoc percutaneous coronary intervention. The rate of adverse events attributable to the procedure was low. The two-year incidence of non-culprit major adverse cardiovascular events was 9 percent, and NIRS IVUS identified patients and non-culprit segments at high risk for future events.<xref ref-type="bibr" rid="article-26927.r10">[10]</xref></p>
              </list-item>
              <list-item>
                <p>In the ADAPT&#x02013;DES study in which 813 STEMI patients were enrolled, IVUS use was associated with improved outcomes in STEMI patients.<xref ref-type="bibr" rid="article-26927.r11">[11]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Shockwave Lithotripsy/Lithoplasty</bold>
<list list-type="bullet"><list-item><p>This system delivers circumferential, pulsatile mechanical energy to disrupt the calcium deposits within&#x000a0;the atherosclerotic lesion. This facilitates stent deployment later.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>PCI in Non-Coronary Vessels</bold>
</p>
        <list list-type="order">
          <list-item>
            <p><bold>PCI in saphenous vein graft:&#x000a0;</bold>Saphenous vein graft is still used in patients undergoing CABG. It usually connects the ascending aorta to the target blood vessel. The rate&#x000a0;of complication in saphenous vein graft is historically higher than left internal mammary graft. Multiple studies have shown poor outcomes with saphenous vein grafts&#x000a0;in long-term follow-up compared with arterial graft. These grafts would usually require PCI if atherosclerosis is worse. DES is preferred compared to other stents, if possible, based on antiplatelet therapy requirements.<xref ref-type="bibr" rid="article-26927.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p><bold>PCI in the Left Internal Mammary Vessel:</bold>&#x000a0;Left internal mammary artery, which is now preferred as a conduit for CABG, has a better survival rate compared with a saphenous vein graft.&#x000a0; However, when compared after PCI, LIMA had 50% residual stenosis and repeat CABG requirements in the hospital, compared with saphenous vein graft PCI.<xref ref-type="bibr" rid="article-26927.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s9" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Coronary Artery or Aortic Injury</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Dissection</p>
          </list-item>
          <list-item>
            <p>Rupture</p>
          </list-item>
        </list>
        <p>
<bold>Bleeding</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Usually, at the access site, groin (femoral approach) or wrist (radial approach). It could be internal or external.</p>
          </list-item>
        </list>
        <p>
<bold>Infection</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Local: involving the infection of the access site.</p>
          </list-item>
          <list-item>
            <p>Systemic: bacteremia&#x000a0;after percutaneous coronary intervention.</p>
          </list-item>
        </list>
        <p>
<bold>Renal Failure</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The contrast used in angiograms can worsen renal function, especially in patients with prior renal dysfunction.</p>
          </list-item>
        </list>
        <p>
<bold>Stroke</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>From blood clots generated during the procedure.</p>
          </list-item>
        </list>
        <p>
<bold>Myocardial Infarction</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>secondary to dissection or thrombosis. Thrombosis could be within the stent or distal to PCI from plaque debris.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>&#x000a0;Complication Rate Increased</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Age greater than 65 years</p>
          </list-item>
          <list-item>
            <p>Female gender</p>
          </list-item>
          <list-item>
            <p>Renal dysfunction</p>
          </list-item>
          <list-item>
            <p>Diabetes</p>
          </list-item>
          <list-item>
            <p>Systolic heart disease</p>
          </list-item>
          <list-item>
            <p>Extensive coronary artery disease</p>
          </list-item>
          <list-item>
            <p>Low BMI patients (higher inpatient bleeding complications)<xref ref-type="bibr" rid="article-26927.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Percutaneous coronary intervention is being used extensively over the last many years. 80% of PCI is being done with stents. Over the past 20 years, short-term mortality, MI, and target vessel revascularization have shown a significant reduction in patients with PCI.&#x000a0;</p>
        <p>Comparing the outcomes in different trials for PCI vs. CABG and medical therapy, the following are the preferred treatments for different patient categories.&#x000a0;SYNTAX score is a tool used to estimate the complexity of coronary lesions and helps determine the decision-making process between PCI or CABG.<xref ref-type="bibr" rid="article-26927.r15">[15]</xref><xref ref-type="bibr" rid="article-26927.r16">[16]</xref></p>
        <p>
<bold>PCI vs. CABG</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>CABG is preferred in patients with two or three-vessel disease with high SYNTAX scores.<xref ref-type="bibr" rid="article-26927.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>CABG is also preferred in patients with the left main disease or one or two-vessel disease and low SYNTAX score.</p>
          </list-item>
          <list-item>
            <p>CABG has shown better outcomes with multivessel disease in patients with diabetes compared with PCI.<xref ref-type="bibr" rid="article-26927.r18">[18]</xref><xref ref-type="bibr" rid="article-26927.r19">[19]</xref><xref ref-type="bibr" rid="article-26927.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>LIMA to LAD graft has better survival irrespective of other grafts present.<xref ref-type="bibr" rid="article-26927.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Studies have shown better patency of&#x000a0;internal mammary graft compared with SVG.<xref ref-type="bibr" rid="article-26927.r22">[22]</xref></p>
          </list-item>
        </list>
        <p>
<bold>PCI vs. Medical Therapy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Medical therapy with high-dose statins is preferred over balloon angioplasty in patients with mild anginal symptoms.<xref ref-type="bibr" rid="article-26927.r23">[23]</xref><xref ref-type="bibr" rid="article-26927.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>PCI is preferred over medical therapy if the patient has;
<list list-type="bullet"><list-item><p>Severe symptoms</p></list-item><list-item><p>Failed medical therapy</p></list-item><list-item><p>High-risk coronary anatomy</p></list-item><list-item><p>Worsening LV function</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26927.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional heart team approach is recommended in patients with multivessel disease or severe left main disease and a high Syntax score. This team includes the family clinician, cardiologist, mid-level practitioners, and cardiology specialty-trained nurses. The team consists of interventional cardiology and cardiac surgery. Pharmacists can offer input for post-procedure medications and perform medication reconciliation.</p>
        <p>Same-day discharge after percutaneous coronary intervention showed comparable results with overnight admission in two metanalyses.<xref ref-type="bibr" rid="article-26927.r25">[25]</xref></p>
      </sec>
      <sec id="article-26927.s12" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>
<bold>Early Team Discharge&#x000a0;in Patients with STEMI after PCI</bold>
</p>
        <p>In low-risk patients with ST-elevation MI, who undergo percutaneous coronary intervention, early discharge&#x000a0;(defined as discharge at 72 hours) had shown improved outcomes.</p>
        <p>One study used the Zwolle risk index and&#x000a0;classified two-third of its patients at low risk of 3 or less [classified as a low risk]. Mortality for these patients was 0.1% at 2 days and 0.2% from 2 to 10 days post; therefore, it was suggested that such patients could be discharged safely after 48 hours of PCI.</p>
        <p>PAMI-2 Trial had low-risk patients after PCI assigned to accelerated care or traditional care. Patients with accelerated care received a discharge on day 3. They showed a significant cost reduction. There was no difference in mortality, unstable angina, reinfarction, stroke, and heart failure between the 2 groups at 6 months.</p>
      </sec>
      <sec id="article-26927.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26927&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26927">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26927/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26927">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26927.s14">
        <title>References</title>
        <ref id="article-26927.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keeley</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Boura</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Grines</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Jan</month>
            <day>04</day>
            <volume>361</volume>
            <issue>9351</issue>
            <fpage>13</fpage>
            <page-range>13-20</page-range>
            <pub-id pub-id-type="pmid">12517460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Vesterlund</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Grande</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abildgaard</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Thayssen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mortensen</surname>
                <given-names>LS</given-names>
              </name>
              <collab>DANAMI-2 Investigators</collab>
            </person-group>
            <article-title>Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).</article-title>
            <source>Am Heart J</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>146</volume>
            <issue>2</issue>
            <fpage>234</fpage>
            <page-range>234-41</page-range>
            <pub-id pub-id-type="pmid">12891190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Blankenship</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cercek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Khot</surname>
                <given-names>UN</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moussa</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Ascheim</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Brindis</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>de Lemos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Diercks</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Linderbaum</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Newby</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Ornato</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Radford</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tamis-Holland</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tommaso</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>DX</given-names>
              </name>
            </person-group>
            <article-title>2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2016</year>
            <month>Mar</month>
            <day>15</day>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>1235</fpage>
            <page-range>1235-1250</page-range>
            <pub-id pub-id-type="pmid">26498666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNamara</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Herrin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Magid</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Blaney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frederick</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <collab>NRMI Investigators</collab>
            </person-group>
            <article-title>Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2006</year>
            <month>Jun</month>
            <day>06</day>
            <volume>47</volume>
            <issue>11</issue>
            <fpage>2180</fpage>
            <page-range>2180-6</page-range>
            <pub-id pub-id-type="pmid">16750682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capodanno</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alfonso</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Valgimigli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Angiolillo</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>ACC/AHA Versus ESC Guidelines on Dual&#x000a0;Antiplatelet Therapy: JACC Guideline Comparison.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2018</year>
            <month>Dec</month>
            <day>11</day>
            <volume>72</volume>
            <issue>23 Pt A</issue>
            <fpage>2915</fpage>
            <page-range>2915-2931</page-range>
            <pub-id pub-id-type="pmid">30522654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brindis</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Fihn</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Newby</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Sabatine</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.</article-title>
            <source>Circulation</source>
            <year>2016</year>
            <month>Sep</month>
            <day>06</day>
            <volume>134</volume>
            <issue>10</issue>
            <fpage>e123</fpage>
            <page-range>e123-55</page-range>
            <pub-id pub-id-type="pmid">27026020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loubeyre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morice</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lef&#x000e8;vre</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pi&#x000e9;chaud</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Louvard</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dumas</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2002</year>
            <month>Jan</month>
            <day>02</day>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-21</page-range>
            <pub-id pub-id-type="pmid">11755281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdel-Wahab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richardt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Joachim B&#x000fc;ttner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Toelg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geist</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Meinertz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schofer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Khattab</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-9</page-range>
            <pub-id pub-id-type="pmid">23266232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kishi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hiasa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ogata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Murata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miyamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hosokawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tanimoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Otani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Comparison of results of rotational atherectomy for diffuse coronary artery disease in diabetics versus nondiabetics.</article-title>
            <source>Am J Cardiol</source>
            <year>2001</year>
            <month>Apr</month>
            <day>01</day>
            <volume>87</volume>
            <issue>7</issue>
            <fpage>894</fpage>
            <page-range>894-6</page-range>
            <pub-id pub-id-type="pmid">11274947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waksman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Di Mario</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Torguson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Skinner</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Artis</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Cate</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Regar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wykrzykowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dube</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kazziha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van der Ent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Kolm</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Garcia-Garcia</surname>
                <given-names>HM</given-names>
              </name>
              <collab>LRP Investigators</collab>
            </person-group>
            <article-title>Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.</article-title>
            <source>Lancet</source>
            <year>2019</year>
            <month>Nov</month>
            <day>02</day>
            <volume>394</volume>
            <issue>10209</issue>
            <fpage>1629</fpage>
            <page-range>1629-1637</page-range>
            <pub-id pub-id-type="pmid">31570255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Witzenbichler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maehara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weisz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Metzger</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Stuckey</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Mazzaferri</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parise</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jan</month>
            <day>28</day>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-70</page-range>
            <pub-id pub-id-type="pmid">24281330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Redfors</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>G&#x000e9;n&#x000e9;reux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Witzenbichler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McAndrew</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Maehara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weisz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kirtane</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous Coronary Intervention of Saphenous Vein Graft.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2017</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">28495896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tajti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Karatasakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karmpaliotis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alaswad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jaffer</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mahmud</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Doing</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Toma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Uretsky</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kirtane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Hatem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Karacsonyi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Danek</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Rangan</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ungi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Brilakis</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>89</fpage>
            <page-range>89-96</page-range>
            <pub-id pub-id-type="pmid">29138364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Numasawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kohsaka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Noma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Momiyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Naito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>e0124399</fpage>
            <pub-id pub-id-type="pmid">25874887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Head</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Davierwala</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Redwood</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Morice</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>St&#x000e5;hle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dawkins</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Kappetein</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.</article-title>
            <source>Eur Heart J</source>
            <year>2014</year>
            <month>Oct</month>
            <day>21</day>
            <volume>35</volume>
            <issue>40</issue>
            <fpage>2821</fpage>
            <page-range>2821-30</page-range>
            <pub-id pub-id-type="pmid">24849105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farmer</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Strategies for multivessel revascularization in patients with diabetes: the FREEDOM trial.</article-title>
            <source>Curr Atheroscler Rep</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>7</issue>
            <fpage>426</fpage>
            <pub-id pub-id-type="pmid">24873916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohr</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Morice</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kappetein</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>St&#x000e5;hle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Morel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Van Dyck</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Houle</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Dawkins</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.</article-title>
            <source>Lancet</source>
            <year>2013</year>
            <month>Feb</month>
            <day>23</day>
            <volume>381</volume>
            <issue>9867</issue>
            <fpage>629</fpage>
            <page-range>629-38</page-range>
            <pub-id pub-id-type="pmid">23439102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farkouh</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Yanagawa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fitchett</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ahsan</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ruel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheema</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Leiter</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fedak</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Teoh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Latter</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Friedrich</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.</article-title>
            <source>Lancet Diabetes Endocrinol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-28</page-range>
            <pub-id pub-id-type="pmid">24622417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutter</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Nesto</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease.</article-title>
            <source>Diab Vasc Dis Res</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-72</page-range>
            <pub-id pub-id-type="pmid">20368235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bansilal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farkouh</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hueb</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ogdie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dangas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lansky</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Magnuson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ramanathan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanguay</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Muratov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Domanski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bertrand</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.</article-title>
            <source>Am Heart J</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>164</volume>
            <issue>4</issue>
            <fpage>591</fpage>
            <page-range>591-9</page-range>
            <pub-id pub-id-type="pmid">23067919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rastan</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Walther</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kempfert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Merk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holzhey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery?</article-title>
            <source>Circulation</source>
            <year>2009</year>
            <month>Sep</month>
            <day>15</day>
            <volume>120</volume>
            <issue>11 Suppl</issue>
            <fpage>S70</fpage>
            <page-range>S70-7</page-range>
            <pub-id pub-id-type="pmid">19752389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zadina</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moritz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ovitt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Copeland</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Thottapurathu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Krasnicka</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>W</given-names>
              </name>
              <collab>VA Cooperative Study Group #207/297/364</collab>
            </person-group>
            <article-title>Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Dec</month>
            <day>07</day>
            <volume>44</volume>
            <issue>11</issue>
            <fpage>2149</fpage>
            <page-range>2149-56</page-range>
            <pub-id pub-id-type="pmid">15582312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pitt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Waters</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>van Boven</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Title</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shurzinske</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Jul</month>
            <day>08</day>
            <volume>341</volume>
            <issue>2</issue>
            <fpage>70</fpage>
            <page-range>70-6</page-range>
            <pub-id pub-id-type="pmid">10395630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acharjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Hartigan</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Barn</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gosselin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tanguay</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Maron</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kostuk</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Chaitman</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Spertus</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dada</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>O'Rourke</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Boden</surname>
                <given-names>WE</given-names>
              </name>
              <collab>COURAGE Trial Research Group</collab>
            </person-group>
            <article-title>Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.</article-title>
            <source>Am Heart J</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>173</volume>
            <fpage>108</fpage>
            <page-range>108-17</page-range>
            <pub-id pub-id-type="pmid">26920603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26927.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdelaal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Gilchrist</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Bernat</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shroff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Costerousse</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pancholy</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Bertrand</surname>
                <given-names>OF</given-names>
              </name>
            </person-group>
            <article-title>Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-112</page-range>
            <pub-id pub-id-type="pmid">23352820</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
